Related references
Note: Only part of the references are listed.IL-2 and IFN-gamma in the retina of diabetic rats
Siv Johnsen-Soriano et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo
Veronica Azcutia et al.
PLOS ONE (2010)
Immune and Inflammatory Mechanisms of Atherosclerosis
Elena Galkina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
The Relation of Markers of Inflammation and Endothelial Dysfunction to the Prevalence and Progression of Diabetic Retinopathy Wisconsin Epidemiologic Study of Diabetic Retinopathy
Barbara E. K. Klein et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Role of TNF-α in vascular dysfunction
Hanrui Zhang et al.
CLINICAL SCIENCE (2009)
Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy The Multi-Ethnic Study of Atherosclerosis
Thanh T. Nguyen et al.
DIABETES CARE (2009)
Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
P. M. Dodson
EYE (2009)
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
Ronald B. Goldberg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases
Takeru Yoshimura et al.
PLOS ONE (2009)
Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy
Mariusz Nowak et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2008)
Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: Mouse models
Andrei A. Kruglov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Tumor necrosis factor (TNF) biology and cell death
Loris Bertazza et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy
Joanna Adamiec-Mroczek et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
TNF-α is an independent serum marker for proliferative retinopathy in type 1 diabetic patients
Carin Gustavsson et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2008)
Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion
Carin Gustavsson et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease
Ponnalagu Murugeswari et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Soluble ICAM-1 and VCAM-1 as markers of endothelial activation
V. Videm et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Immunological mechanisms in the pathogenesis of diahetic retinopathy
Anthony P. Adamis et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Targeting TNF-alpha receptors for neurotherapeutics
Wayne Chadwick et al.
TRENDS IN NEUROSCIENCES (2008)
Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes
Taoufik Khalfaoui et al.
JOURNAL OF MOLECULAR HISTOLOGY (2008)
Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy
J. I. Patel et al.
EYE (2008)
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A. C. Keech et al.
LANCET (2007)
Obesity-induced inflammation: a metabolic dialogue in the language of inflammation
A. W. Ferrante
JOURNAL OF INTERNAL MEDICINE (2007)
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes
A. M. W. Spijkerman et al.
DIABETIC MEDICINE (2007)
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes
Deepti Navaratna et al.
DIABETES (2007)
Recipes for creating animal models of diabetic cardiovascular disease
Willa Hsueh et al.
CIRCULATION RESEARCH (2007)
Diabetic atherosclerosis mouse models
Kenneth K. Wu et al.
ATHEROSCLEROSIS (2007)
Endothelial signaling by Ig-like cell adhesion molecules
Jaap D. van Buul et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration
Tanyth E. de Gooyer et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Expression of antioxidant enzymes in rat retinal ischemia followed by reperfusion
Carl-David Agardh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients
SS Soedamah-Muthu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Molecular mechanisms involved in T cell migration across the blood-brain barrier
B Engelhardt
JOURNAL OF NEURAL TRANSMISSION (2006)
Modifying a standard method allows simultaneous extraction of RNA and protein, enabling detection of enzymes in the rat retina with low expressions and protein levels
E Agardh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Diabetic retinopathy - Seeing beyond glucose-induced microvascular disease
David A. Antonetti et al.
DIABETES (2006)
The RAGE axis in early diabetic retinopathy
GR Barile et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering?
LA Leiter
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort
TJ Lyons et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy
K Matsumoto et al.
DIABETIC MEDICINE (2002)
Caspase activation in retinas of diabetic and galactosentic mice and diabetic patients
S Mohr et al.
DIABETES (2002)
NF-κB:: pivotal mediator or innocent bystander in atherogenesis?
T Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
